These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 31856634

  • 1. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
    Sık G, Demirbuga A, Annayev A, Citak A.
    Int J Artif Organs; 2020 Apr; 43(4):234-241. PubMed ID: 31856634
    [Abstract] [Full Text] [Related]

  • 2. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP, Fernández Sarmiento J, Rojas Velasquez AM, González Chaparro LS, Gastelbondo Amaya R, Mulett Hoyos H, Tibaduiza D, Quintero Gómez AM.
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [Abstract] [Full Text] [Related]

  • 3. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ, Rajbhandari D, Bradford C, Buhr H, Lo S, Bellomo R.
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [Abstract] [Full Text] [Related]

  • 4. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A, Küllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, Dimski T, Tyczynski B, Jahn M, Mülling N, Mehrländer M, Rosenberger P, Marx G, Simon TP, Jaschinski U, Deetjen P, Putensen C, Schewe JC, Kluge S, Jarczak D, Slowinski T, Bodenstein M, Meybohm P, Wirtz S, Moerer O, Kortgen A, Simon P, Bagshaw SM, Kellum JA, Meersch M, RICH Investigators and the Sepnet Trial Group.
    JAMA; 2020 Oct 27; 324(16):1629-1639. PubMed ID: 33095849
    [Abstract] [Full Text] [Related]

  • 5. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
    Gould DW, Doidge J, Sadique MZ, Borthwick M, Hatch R, Caskey FJ, Forni L, Lawrence RF, MacEwen C, Ostermann M, Mouncey PR, Harrison DA, Rowan KM, Young JD, Watkinson PJ.
    Health Technol Assess; 2022 Feb 27; 26(13):1-58. PubMed ID: 35212260
    [Abstract] [Full Text] [Related]

  • 6. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA, Lilien M, van Kessel IA, Veldhoen ES, Wösten-van Asperen RM, van Gestel JPJ.
    Pediatr Nephrol; 2017 Oct 27; 32(10):1971-1978. PubMed ID: 28578542
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Regional citrate versus heparin anticoagulation in continuous renal replacement therapy in critically ill patients: a Meta-analysis].
    Feng X, Deng L, Zhang Y, Chang L.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug 27; 32(8):982-987. PubMed ID: 32912414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L, Nurmohamed SA, Bosch FH, Purmer IM, den Boer SS, Kleppe CG, Vervloet MG, Beishuizen A, Girbes AR, Ter Wee PM, Groeneveld AB, CASH study group.
    Crit Care; 2014 Aug 16; 18(4):472. PubMed ID: 25128022
    [Abstract] [Full Text] [Related]

  • 14. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study.
    Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P.
    Intensive Care Med; 2004 Feb 16; 30(2):260-265. PubMed ID: 14600809
    [Abstract] [Full Text] [Related]

  • 15. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs.
    Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, Wang P, Li L, Jing R, Zhao L, Sun S.
    Intensive Care Med; 2015 Dec 16; 41(12):2098-110. PubMed ID: 26482411
    [Abstract] [Full Text] [Related]

  • 16. Epoprostenol (Prostacyclin Analog) as a Sole Anticoagulant in Continuous Renal Replacement Therapy for Critically Ill Children With Liver Disease: Single-Center Retrospective Study, 2010-2019.
    Deep A, Alexander EC, Khatri A, Kumari N, Sudheendhra K, Patel P, Joarder A, Elghuwael I.
    Pediatr Crit Care Med; 2024 Jan 01; 25(1):15-23. PubMed ID: 38169336
    [Abstract] [Full Text] [Related]

  • 17. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Liu C, Mao Z, Kang H, Hu J, Zhou F.
    Crit Care; 2016 May 13; 20(1):144. PubMed ID: 27176622
    [Abstract] [Full Text] [Related]

  • 18. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW, Foringer JR.
    Ren Fail; 2005 May 13; 27(5):541-5. PubMed ID: 16152991
    [Abstract] [Full Text] [Related]

  • 19. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients.
    Kutsogiannis DJ, Gibney RT, Stollery D, Gao J.
    Kidney Int; 2005 Jun 13; 67(6):2361-7. PubMed ID: 15882280
    [Abstract] [Full Text] [Related]

  • 20. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.
    Palsson R, Laliberte KA, Niles JL.
    Clin Nephrol; 2006 Jan 13; 65(1):34-42. PubMed ID: 16429840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.